TECTYL 275

Hazardous Ingredients

OSHA Component Wt.% Recommended Exposure Limits Aliphatic Petroleum Solvent 30-40 OSHA PEL: 100 ppm CAS #64742-88-7 ACGIH TLV: 100 ppm Petroleum Oil (Severely solvent-refined 30-40 OSHA PEL: Not Established and/or severely hydrotreated) ACGIH TLV: 5 mg/m3 (mists) CAS #64741-96-4 and/or #64742-52-5 [1] Ethylene Glycol Butyl Ether 13-18 ACGIH TLV: 25 ppm CAS #111-76-2 OSHA PEL: 25 ppm [1] See Section 3 SECTION 3: HEALTH HAZARD INFORMATION Primary Routes of Entry: Inhalation, skin absorption. Acute Effects: Excessive inhalation may produce dizziness, nausea, headache, and incoordination. May cause skin irritation and severe eye irritation. Prolonged skin exposure may cause dermatitis, defatting of the skin , or oil acne. Breathing mists may cause dizziness or pulmonary irritation. Chronic Effects of Ethylene Glycol Butyl Ether: Inhalation: A single prolonged (hours) excessive inhalation exposure may cause adverse effects. Excessive exposure may cause irritation to upper respiratory tract. Observations in animals include blood, kidney, lung and liver effects. The LC50 for rats is 700 ppm in 7 hours. Systemic & other Effects: Observations in animals include blood, kidney, lung and liver effects. Observations in animals include testiculara atrophy only after repeated oral administration. Testicular atrophy has not been observed with other routes of exposure. Birth defects are unlikely. Exposures having no effect on the mother should have no effect on the fetus. Did not cause birth defects in animals; other effects were seen in the fetus only at doses which caused toxic effects to the mother. Results of mutagenicity tests in animals have been negative. Results of in vitro ("test tube") mutagenicity tests have been inconclusive. Carcinogenicity: None of the components of this product are listed as carcinogens by NTP, IARC, or OSHA 1910(Z). Pre-Existing Medical Conditions Aggravated by Exposure: Exposure may aggravate pre-existing respiratory or skin problems.